Syringes and cannulas have seen significant technical advancements throughout the forecast period, from 2021to 2031. With the use of multi-chamber syringes, better lubrication technology, and the advent of needle-stick safety-equipped devices, amongst various other technical advancements linked to disposable syringes, has increased demand for disposable syringes throughout regions. In addition, the emergence of different safety measures such as sophisticated retractable needle systems and passive needle guards with a plastic shield is tackling the problem of needle-stick injuries in a significant way. Advancements in syringe decrease the combined concerns of syringe reuse and unintentional needle stick injuries. Syringes with automatic retraction technology, for example, prevent the possibility of a compromised needlestick and sharp injuries to healthcare personnel. Furthermore, the automatic withdrawal of the needle essentially prevents the instrument from being reused. As a result, recent technical improvements are a significant driving reason behind growing syringe and cannula demand, which is likely to support growth of the global syringes and cannulas market in the years to come.
Transparency market research offers a comprehensive understanding of the global syringes and cannulas market through this report. It provides well-researched data on a wide variety of market aspects in order to provide useful business input for profit making.
Expanding operations in future? To get the perfect launch ask for a custom report
Applied Medical Devices Corporation stated in October 2017 that it will expand its medical device production and research and development facilities in Europe and Middle East and Africa.
The noted players that are operational in the global syringes and cannulas market are Abu Dhabi Medical Devices Company, Hindustan Syringes & Medical Devices Ltd., Selia-Tek Medical Sdn Bhd, Applied Medical Resources Corporation, Schott Kaisha Private Limited, and Becton Dickinson and Co.
Below-mentioned market trends and opportunities mark the global syringes and cannulas market:
As the incidence of infectious illnesses and contagious disorders rises, the demand for reusable and disposable syringes is projected to rise. The number of vaccination efforts undertaken by government as well as non-governmental groups has increased significantly, resulting in augmented demand in the global syringes and cannulas market in the near future.
In addition, the growing number of medical operations that need cannulas is projected to boost demand. Developments in healthcare infrastructure are contributing to an increase in the number of clinics in undeveloped areas. Market expansion for syringes and cannulas is likely to be aided by an increase in the number of manufacturers of medical device in countries such as China and India.
Demand for syringes and cannulas is projected to rise across territories as the prevalence of chronic disorders and pandemics such as COVID19 rise. Leading biopharmaceutical companies are concentrating their efforts on creating vaccinations to combat the illness. As a result of rising vaccine demand and the start of global immunization campaigns, syringe demand is at its all-time high. Because of its low cost and large production capacity, countries like India are anticipated to see a surge in syringe demand. Several medical equipment companies have begun producing and storing syringes in anticipation of future demand. In the case of cannulas, however, there has been a considerable decrease in hospital visits of patients, as well as a drop in the number of procedures, resulting in a negative influence on market growth.
Request a sample to get extensive insights into the Syringes and Cannulas Market
The syringe and cannula market in North America is expected to be one of the most rewarding regions. With the presence of several notable players in the region, the US is a major contributor towards the growth of the North America market.
The US comes with a high rate of syringe and cannula commercialization and approval, accounting for a substantial chunk of North America revenue. In addition, the US Food and Drug Administration's tough restrictions against the reuse of single-use syringes is likely to bode well for the country's growth. Furthermore, the country's well-developed healthcare infrastructure has attracted a huge number of patients seeking complicated treatments, which is estimated to aid market expansion.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.